NY-LINEAGE-LOGISTICS
23.3.2020 21:09:09 CET | Business Wire | Press release
Kyrie Irving has partnered with Lineage Logistics , the world’s largest and most innovative provider of temperature-controlled logistics, and Feeding America® , the nation’s largest hunger-relief organization, to raise awareness for its Share A Meal campaign, which aims to help provide 100 million meals* in response to COVID-19. The campaign goal is to help ensure no family or child goes hungry during this global pandemic.
Kyrie is personally contributing $323,000, and is asking his family, friends, fans and partners to join him in donating in support of Feeding America’s COVID-19 Response Fund. Lineage Logistics will match all donations up to $200,000 to City Harvest, New York City’s private response to hunger and largest food rescue organization, and in addition, Kyrie and Lineage are donating over 250,000 meals** to City Harvest to immediately help those affected by COVID-19.
“Seeing the effects of COVID-19 reach our families, our schools, our jobs, and access to food has really impacted me,” said Kyrie. “I am excited to partner with Feeding America and Lineage Logistics to launch the Share A Meal campaign to help marginalized communities get the food resources they require during this time, and to work with City Harvest to distribute meals to my neighbors in need across the New York area. Thank you to everyone on the front line working to keep all of us safe, healthy, and fed. Together we can change the world one small gesture at a time."
“The COVID-19 virus presents extraordinary challenges for moving, storing, and distributing food on a large scale,” said Greg Lehmkuhl, Lineage’s President & CEO. “At Lineage, we’ve built a business dedicated to shepherding food all over the world, and that experience puts us in a unique position to help overcome these challenges. We want to do our part by sharing what we have to offer – including temperature-controlled warehouse space, supply chain logistics expertise and financial resources.”
City Harvest is dedicated to feeding New Yorkers who are struggling to put meals on their tables, and in response to the COVID-19 crisis and its devastating economic impact, the organization is stepping up to rescue and deliver more food to meet the increasing need. Deemed an essential service by Governor Cuomo and New York State, its fleet of 22 trucks will continue to be on the road, working hard to make sure all children, families, and New Yorkers in need have enough nutritious food in the coming weeks, months, and beyond.
Lineage is working with a variety of strategic partners, including Kyrie and Stephen and Ayesha Curry’s foundation, Eat. Learn. Play., to achieve its campaign goal of 100 million meals. Recognizing that COVID-19 is a worldwide crisis, Lineage is working with the Global FoodBanking Network , to provide funds, donate food, and volunteer the company’s storage resources and distribution expertise on a global scale. The Company will also leverage its expansive network of customers, which includes some of the world’s largest food producers and manufacturers, to join Lineage in its commitment to reach Share A Meal ’s ambitious goal.
To join the Share A Meal effort and support Feeding America and City Harvest, please visit http://feedingamerica.org/kyrie-covid .
*100 million meal equivalent will include financial and in-kind donations facilitated by Lineage and its partners to Feeding America and other hunger-relief organizations.
**The 250,000 meal donation is equivalent to 25,000 pounds of food being donated to City Harvest as well as a $25,000 monetary donation, according to the following calculation: $1 = 10 meals.
About Lineage Logistics
Lineage is the world’s largest and most innovative provider of temperature-controlled logistics solutions. Lineage’s expertise in end-to-end logistical solutions, its unrivaled facility network, and its use of technology combine to promote food safety, increase distribution efficiency, advance sustainability, lessen environmental impact, and minimize supply chain waste. As a result, Lineage helps customers ranging from Fortune 500 companies to small family-owned businesses increase the efficiency and protect the integrity of their temperature-controlled supply chain. In recognition of the company’s leading innovations, Lineage was recognized as the No 1. Data Science company on Fast Company’s Annual list of The World’s Most Innovative Companies in 2019, in addition to ranking 23rd overall in an evaluation of thousands of companies worldwide. For more information, visit: www.lineagelogistics.com .
About City Harvest
City Harvest is New York City’s largest food rescue organization, helping to feed the nearly 1.2 million New Yorkers who are struggling to put meals on their tables. We will rescue 66 million pounds of food this year and deliver it, free of charge, to hundreds of soup kitchens, food pantries, and other community partners across the five boroughs. Our programs empower individuals through nutrition education, increase our partners’ capacity, and strengthen the local food system, helping New Yorkers who are experiencing food insecurity to access, afford, and consume nutritious food. To learn more about our work, visit www.cityharvest.org
About Feeding America®
Feeding America® is the largest hunger-relief organization in the United States. Through a network of 200 food banks and 60,000 food pantries and meal programs, we provide meals to more than 40 million people each year. Feeding America also supports programs that prevent food waste and improve food security among the people we serve; educates the public about the problem of hunger; and advocates for legislation that protects people from going hungry. Individuals, charities, businesses and government all have a role in ending hunger. Donate. Volunteer. Advocate. Educate. Together we can solve hunger. Visit www.feedingamerica.org , find us on Facebook or follow us on Twitter .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200323005660/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
